Literature DB >> 18946642

[Modern therapy of diverticular disease].

L Leifeld1, W Kruis.   

Abstract

New concepts are developed in the therapy of diverticular disease. 5-aminosalicylates can be administered in patients with slight forms of diverticulitis. In moderate diverticulitis antibiotics should be applied alternatively or additionally. In cases of severe diverticulitis patients should be kept fasting with parenteral nutrition and intravenous broad spectrum antibiotics. Small abscesses can be treated conservatively while abscesses larger than 4 cm should be drained in a first step and than treated surgically. A free perforation is still an absolute indication for emergency operation. In recurring diverticulitis indication for resection of the affected segment of the bowel should be considered depending on the extent of former attacks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946642     DOI: 10.1007/s00108-008-2150-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

1.  Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.

Authors:  A Tursi; G Brandimarte; R Daffinà
Journal:  Dig Liver Dis       Date:  2002-07       Impact factor: 4.088

2.  Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study.

Authors:  K Campbell; R J Steele
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

3.  Practice parameters for sigmoid diverticulitis.

Authors:  Janice Rafferty; Paul Shellito; Neil H Hyman; W Donald Buie
Journal:  Dis Colon Rectum       Date:  2006-07       Impact factor: 4.585

Review 4.  Clinical practice. Diverticulitis.

Authors:  Danny O Jacobs
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

5.  Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study.

Authors:  R G Wilson; A N Smith; I M Macintyre
Journal:  Br J Surg       Date:  1991-09       Impact factor: 6.939

6.  Efficacy of mesalazine in the treatment of symptomatic diverticular disease.

Authors:  Francesco Di Mario; Giovanni Aragona; Gioacchino Leandro; Giuseppe Comparato; Libera Fanigliulo; Lucas G Cavallaro; Giulia M Cavestro; Veronica Iori; Marta Maino; Alì M Moussa; Alessandro Gnocchi; Giancarlo Mazzocchi; Angelo Franzé
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

7.  The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon.

Authors:  Pruemysl Fric; Miroslav Zavoral
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-03       Impact factor: 2.566

8.  The management of massive lower gastrointestinal bleeding.

Authors:  B M Parkes; F N Obeid; V J Sorensen; H M Horst; J J Fath
Journal:  Am Surg       Date:  1993-10       Impact factor: 0.688

9.  Incidence of perforated diverticulitis and risk factors for death in a UK population.

Authors:  C R Morris; I M Harvey; W S L Stebbings; A R Hart
Journal:  Br J Surg       Date:  2008-07       Impact factor: 6.939

10.  Role of colonoscopy in patients with persistent acute diverticulitis.

Authors:  Adi Lahat; Henit Yanai; Emad Sakhnini; Yoram Menachem; Simon Bar-Meir
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

View more
  1 in total

Review 1.  Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review.

Authors:  Taras Gout; Andrew J K Ostör; Muhammad K Nisar
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.